Diarrhea-Associated Hemolytic Uremic Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Diarrhea-Associated Hemolytic Uremic Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT06389474

Efficacy of INM004 in Children With STEC-HUS

The objectives of this study are to evaluate the efficacy, safety, and pharmacokinetics of INM004 in pediatric patients with Hemolytic Uremic Syndrome associate…

Argentina220 participantsStarted 2024-10-05

Treatment: INM004, Placebo

All recent trials (2 shown)

CompletedPhase 2

NCT05569746

A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS

Hemolytic Uremic Syndrome (HUS) is a foodborne disease which mainly affects children. It is caused by Escherichia coli bacteria, which release a toxin called Sh…

Argentina57 participantsStarted 2022-10-06

Treatment: INM004, SoC